Neurovascular Devices Market Growth, Size, Trends Analysis - By Device, By Therapeutic Application, By End-Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Neurovascular Devices Market Introduction and Overview

According to SPER market research, 'Global Neurovascular Devices Market Size- By Device, By Therapeutic Application, By End-Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Neurovascular Devices Market is predicted to reach 9.24 billion by 2034 with a CAGR of 8.95%.

Neurovascular devices are used to treat neurovascular diseases. Neurovascular devices, such as clips, coils, and stents, are used to treat neurovascular illnesses such brain aneurysms. Similarly, clot retrieval devices, suction, and aspiration equipment are used to remove blood clots from the brain's arteries and veins, which can result in catastrophic disorders such as stroke. Carotid artery stents, distal filter devices, and microcatheters are some more types of neurovascular devices. Furthermore, neurovascular devices are used to treat aneurysms, arteriovenous malformation and fistulas, ischemic stroke, and stenosis.

The global market is being held back by the high cost of neurovascular surgical procedures and equipment, particularly in poorer nations with inadequate reimbursement systems. Furthermore, the overall cost of ownership of these devices is raised by maintenance fees and other related indirect expenditures, which restricts their uptake. Few patients in impoverished nations can afford neurological therapy due to high prices and a poor reimbursement environment.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Device, By Therapeutic Application, By End-Use.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Medtronic, Stryker Corporation, Terumo Corporation, Penumbra, Inc, Johnson & Johnson Services, Inc, Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, MicroPort Scientific Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO, LTD.

Neurovascular Devices Market Segmentation:

By Device: Based on the Device, Global Neurovascular Devices Market is segmented as; Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices.

By Therapeutic Application: Based on the Therapeutic Application, Global Neurovascular Devices Market is segmented as; Stroke, Cerebral Artery, Cerebral Aneurysm, Others.

By End Use: Based on the End Use, Global Neurovascular Devices Market is segmented as; Hospitals, Specialty Clinics, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: MEDE2507

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Neurovascular Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Neurovascular Devices Market

7. Global Neurovascular Devices Market, By Device (USD Million) 2021-2034

7.1. Cerebral Embolization and Aneurysm Coiling Devices
- 7.1.1. Embolic coils
- 7.1.2. Flow diversion devices
- 7.1.3. Liquid embolic agents
7.2. Cerebral Angioplasty and Stenting Systems
- 7.2.1. Carotid artery stents
- 7.2.2. Embolic protection systems
7.3. Neurothrombectomy Devices
- 7.3.1. Clot retrieval devices
- 7.3.2. Suction devices/aspiration catheters
- 7.3.3. Vascular snares
7.4. Support Devices
- 7.4.1. Micro catheters
- 7.4.2. Micro guidewires
7.5. Trans Radial Access Devices

8. Global Neurovascular Devices Market, By Therapeutic Application (USD Million) 2021-2034

8.1. Stroke
8.2. Cerebral Artery
8.3. Cerebral Aneurysm
- 8.3.1. Aneurysmal Subarachnoid Hemorrhage
- 8.3.2. Others
8.4. Others

9. Global Neurovascular Devices Market, By End User (USD Million) 2021-2034

9.1. Hospitals
9.2. Specialty Clinics
9.3. Others

10. Global Neurovascular Devices Market (USD Million) 2021-2034

10.1. Global Neurovascular Devices Market Size and Market Share

11. Global Neurovascular Devices Market, By Region (USD Million) 2021-2034

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Medtronic
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Stryker Corporation
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Terumo Corporation
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Penumbra, Inc
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Johnson & Johnson Services, Inc
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Integra LifeSciences Corporation
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Acandis GmbH
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Spiegelberg GmbH & Co. KG
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. MicroPort Scientific Corporation
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others